New skin cell transplant aims to recolor vitiligo patches
NCT ID NCT07187882
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests a procedure where a person's own skin cells are transplanted onto stable white patches caused by vitiligo. The goal is to see how well and how safely it restores color over the long term. The trial will enroll 30 people with stable vitiligo who have not responded to other treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Autologous non-cultured epidermal cell suspension
- What this could lead to
- If successful, this procedure could offer a safe, effective way to restore skin color in people with stable vitiligo, reducing the need for ongoing treatments.
- What could go wrong
- This is a small, early-stage trial with only 30 participants. Results may not apply to all types of vitiligo, and repigmentation can be incomplete or uneven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VITILIGO are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking University People's Hospital
RECRUITINGBeijing, Beijing Municipality, 100044, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Real-World data unlock better skin disease care?
- New ointment aims to restore skin color in vitiligo
- Skin microbes linked to vitiligo and immunotherapy reactions in melanoma patients
- New vitiligo registry aims to uncover disease trends in 2,500 patients
- Scientists probe immune secrets of four skin diseases
- Lamp vs laser: which light works best for vitiligo?